Advanced Biomed ends $25 million stock purchase deal with Helena Global, effective July 21
Advanced Biomed Inc. gave notice on July 14, 2026 to terminate its June 6, 2025 purchase agreement with Helena Global Investment Opportunities I Ltd., which allowed the company to sell up to $25,000,000 of common stock to the investor at its discretion. The filing states no shares were sold under the agreement apart from commitment fee shares, and the termination takes effect July 21, 2026, so the company will no longer have this equity financing option.
Key points
- Purchase agreement dated June 6, 2025 allowed sales of up to $25,000,000 of common stock to Helena Global Investment Opportunities I Ltd.
- Termination notice delivered July 14, 2026 under Section 11.02(b), which requires five trading days' notice.
- No advances were outstanding and all amounts owed, including commitment fee shares, were paid, per the filing.
- Termination becomes effective July 21, 2026.
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 17, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.